This article has Open Peer Review reports available.
Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer: a proof-of-concept study in the preoperative window period (ImPACCT)
- I. Ubink1,
- H. J. Bloemendal2, 3,
- S. G. Elias4,
- M. A. Brink5,
- M. P. Schwartz5,
- Y. C. W. Holierhoek5,
- P. M. Verheijen6,
- A. W. Boerman3,
- R. H. J. Mathijssen7,
- W. W. J. de Leng8,
- R. A. de Weger8,
- W. M. U. van Grevenstein1,
- M. Koopman2,
- M. P. Lolkema7,
- O. Kranenburg1Email author and
- I. H. M. Borel Rinkes1Email author
© The Author(s). 2017
Received: 29 November 2016
Accepted: 5 April 2017
Published: 19 April 2017
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|29 Nov 2016||Submitted||Original manuscript|
|13 Feb 2017||Author responded||Author comments - Inge Ubink|
|Resubmission - Version 2|
|13 Feb 2017||Submitted||Manuscript version 2|
|5 Apr 2017||Editorially accepted|
|19 Apr 2017||Article published||10.1186/s12885-017-3264-y|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.